4.7 Review

Typical and atypical properties of peripheral nerve allografts enable novel strategies to repair segmental-loss injuries

Journal

JOURNAL OF NEUROINFLAMMATION
Volume 19, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12974-022-02395-0

Keywords

Peripheral nerve allografts; Immunosuppression; Wallerian degeneration; Polyethylene glycol (PEG); T cells

Funding

  1. Lone Star Paralysis Foundation
  2. Department of Defense award [W81XWH-19-2-0054]
  3. University of Wyoming Startup funds
  4. United States Department of Defense grant [W81XWH-17-1-0402]
  5. University of Wyoming Sensory Biology COBRE under National Institutes of Health (NIH) award [5P20GM121310-02]
  6. National Institute of General Medical Sciences of the NIH [P20GM103432]
  7. NIH [R01NS081063]

Ask authors/readers for more resources

Peripheral nerve injuries are the most common type of nervous system injuries, and segmental-loss PNIs have a poor prognosis. Conventional treatment methods have limited progress, but recent advances using viable PNAs have shown potential for functional recovery.
We review data showing that peripheral nerve injuries (PNIs) that involve the loss of a nerve segment are the most common type of traumatic injury to nervous systems. Segmental-loss PNIs have a poor prognosis compared to other injuries, especially when one or more mixed motor/sensory nerves are involved and are typically the major source of disability associated with extremities that have sustained other injuries. Relatively little progress has been made, since the treatment of segmental loss PNIs with cable autografts that are currently the gold standard for repair has slow and incomplete (often non-existent) functional recovery. Viable peripheral nerve allografts (PNAs) to repair segmental-loss PNIs have not been experimentally or clinically useful due to their immunological rejection, Wallerian degeneration (WD) of anucleate donor graft and distal host axons, and slow regeneration of host axons, leading to delayed re-innervation and producing atrophy or degeneration of distal target tissues. However, two significant advances have recently been made using viable PNAs to repair segmental-loss PNIs: (1) hydrogel release of Treg cells that reduce the immunological response and (2) PEG-fusion of donor PNAs that reduce the immune response, reduce and/or suppress much WD, immediately restore axonal conduction across the donor graft and re-innervate many target tissues, and restore much voluntary behavioral functions within weeks, sometimes to levels approaching that of uninjured nerves. We review the rather sparse cellular/biochemical data for rejection of conventional PNAs and their acceptance following Treg hydrogel and PEG-fusion of PNAs, as well as cellular and systemic data for their acceptance and remarkable behavioral recovery in the absence of tissue matching or immune suppression. We also review typical and atypical characteristics of PNAs compared with other types of tissue or organ allografts, problems and potential solutions for PNA use and storage, clinical implications and commercial availability of PNAs, and future possibilities for PNAs to repair segmental-loss PNIs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available